Interestingly, TERT promoter mutations were not detected in the benign hepatocellular adenoma; in contrast, 7/16 (48%) malignant tumors transformed from HCA and 58/106 (55%) of HCCs in normal liver exhibited the mutations, all of which are significantly associated with mutations activating canonical WNT signaling pathway. Here, TERT is linked to hepatocellular adenoma.